Synopsis:
Welspun Enterprises gained a Rs. 3,145 crore order to construct a 910 MLD water remedy plant in Maharashtra, increasing its order guide and water sector presence.
Identified for executing large-scale infrastructure and water administration tasks, the corporate has secured a big contract to construct a significant water remedy plant in Maharashtra. The next information explores particulars of this undertaking, its partnership scope, execution timeline, and the way it strengthens the corporate’s order guide and sector presence.
Welspun Enterprises Restricted‘s inventory, with a market capitalisation of Rs. 7,519 crores, rose to Rs. 562.80, hitting a excessive of as much as 2.69 % from its earlier closing worth of Rs. 548.05. Moreover, the inventory over the previous yr has given a return of 9 %.
Order Particulars
The corporate has obtained a significant order to construct a brand new 910 million liters per day (MLD) water remedy plant at Panjrapur, Maharashtra. The full contract worth is about Rs. 3,145 crore, which incorporates working and sustaining the plant for 15 years after development. This undertaking will probably be accomplished with expertise from Veolia Water Applied sciences, Malaysia, and is predicted to be accomplished inside 48 months.
With this new order, Welspun’s whole excellent order guide has elevated to round Rs. 16,330 crore. Most of those orders are from the water sector, in addition to tunnel and transportation tasks. The corporate has been steadily rising its enterprise within the water sector and is taking on larger tasks in Mumbai.
In response to the Chairman, Mr. B.Okay. Goenka, as soon as this undertaking and one other massive one at Bhandup are completed, almost 70% of Mumbai’s freshwater wants will probably be managed by Welspun. The corporate can be making progress on different necessary water tasks, aiming to enhance water reuse and promote sustainability consistent with its guiding rules.
Q1 Monetary Highlights
Income in Q1FY26 stood at Rs. 845 crore, declining by 19.8% QoQ from Rs. 1,054 crore in Q4FY25 and falling 9.1% YoY from Rs. 930 crore in Q1FY25. This marks a notable slowdown in comparison with the corporate’s robust 3-year gross sales CAGR of 39%. The income contraction suggests strain on topline progress in each sequential and annual phrases.
Web revenue for Q1FY26 was Rs. 101 crore, down 3.8% QoQ from Rs. 105 crore and eight.2% YoY from Rs. 110 crore. Revenue efficiency, whereas exhibiting near-term weak point, stays wholesome over the long term with a 3-year revenue CAGR of 38% and ROE CAGR of 13%. Sequential and YoY declines, nevertheless, mirror latest margin or demand challenges.
Written By Fazal Ul Vahab C H
Disclaimer
The views and funding ideas expressed by funding consultants/broking homes/ranking companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of economic losses. Buyers should due to this fact train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Personal Restricted or the writer are usually not chargeable for any losses precipitated because of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
